Kasauli/Solan (Himachal Pradesh): Amidst the ongoing war with Corona's new variant of Omicron, BF.7, the country's first batch of Bharat Biotech's nasal vaccine has reached the Central Drugs Laboratory (CDL) in Kasauli for quality and control testing. After receiving recognition from the CDL, this will be the first vaccine to be administered through the nose. Recently, the Drug Controller General of India approved the emergency use of this vaccine.
After getting approval from CDL, this will be the first vaccine administered through the nose. The vaccine has been recently approved by Dr V. G. Somani, the Drug Controller General of India (DCGI), for emergency use. According to Sushil Sahu, the Director of the Central Drugs Laboratory, intensive testing of the vaccine has already begun, and the results will be out in the next few days.